Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Retained Earnings (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Retained Earnings data on record, last reported at -$463.3 million in Q4 2025.

  • For Q4 2025, Retained Earnings fell 18.64% year-over-year to -$463.3 million; the TTM value through Dec 2025 reached -$463.3 million, down 18.64%, while the annual FY2025 figure was -$463.3 million, 18.64% down from the prior year.
  • Retained Earnings reached -$463.3 million in Q4 2025 per PLSE's latest filing, down from -$445.8 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$191.2 million in Q1 2021 and bottomed at -$463.3 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$318.3 million, with a median of -$304.6 million recorded in 2022.
  • Peak YoY movement for Retained Earnings: plummeted 22080100.0% in 2021, then fell 14.0% in 2024.
  • A 5-year view of Retained Earnings shows it stood at -$220.8 million in 2021, then tumbled by 33.47% to -$294.7 million in 2022, then fell by 14.32% to -$336.9 million in 2023, then decreased by 15.9% to -$390.5 million in 2024, then decreased by 18.64% to -$463.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were -$463.3 million in Q4 2025, -$445.8 million in Q3 2025, and -$426.5 million in Q2 2025.